Mistletoe Injection for Prostate Cancer: A Natural Supportive Therapy

Prostate cancer is among the most common cancers in men worldwide, and its impact is steadily increasing in India as well. While surgery, chemotherapy, hormone therapy, and radiation remain the backbone of prostate cancer treatment, patients and doctors are increasingly looking toward integrative therapies to improve quality of life and enhance treatment outcomes.

One such integrative approach is the use of Mistletoe Injections (abnobaVISCUM®), developed by ABNOBA GmbH, a German research-based pharmaceutical company. Through its official partner ABNOBA India, this therapy has now become available for patients in India.

What is Mistletoe Therapy?

Mistletoe (Viscum album) is a medicinal plant that has been used in European oncology for nearly a century. The plant extract is processed into injections, which are administered subcutaneously (under the skin).

The active ingredients—lectins, viscotoxins, and polysaccharides—work together to:

  • Boost the immune system by activating natural killer cells and macrophages.

  • Trigger cancer cell death (apoptosis).

  • Improve tolerance to conventional therapies like chemotherapy and radiotherapy.

  • Enhance quality of life by reducing fatigue, improving appetite, sleep, and emotional well-being.

Mistletoe Injection for Prostate Cancer

ABNOBA GmbH has developed specific protocols for prostate cancer patients, which are now followed internationally:

  • Initial phase: Patients start with very low doses (0.02 mg) injected three times a week.

  • Escalation phase: Doses are gradually increased depending on the patient’s tolerance and general condition.

  • Maintenance phase: Continued use over 2–3 years helps sustain the therapeutic benefit, with breaks as recommended.

These protocols are adjusted individually for:

  • Patients in good health,

  • Patients with weaker general condition,

  • Patients with metastatic prostate cancer.

Expected Benefits for Prostate Cancer Patients

  • Strengthening the body’s defense system during cancer therapy.

  • Supporting recovery after surgery or radiation.

  • Helping manage side effects of chemotherapy or hormone therapy.

  • Promoting overall well-being and better quality of life.

Safety and Side Effects

Mistletoe injections are generally well tolerated. Common and expected reactions include:

  • Mild redness or swelling at the injection site (a sign of immune activation).

  • Slight fever (0.5–1°C rise).

  • Temporary tiredness or headache.

These effects usually indicate that the therapy is working. If reactions are too strong, doctors adjust the dosage accordingly.

Mistletoe Therapy in India

In 2023, ABNOBA India, in collaboration with Art of Healing Cancer (Gurugram), introduced mistletoe injections in India.

  • Treatment is available under a special drug license issued on a patient-specific basis.

  • Therapy is always prescribed and monitored by qualified oncologists.

  • Data from Indian patients will also contribute to ongoing global research on mistletoe therapy.

Conclusion

Mistletoe injection therapy (abnobaVISCUM®) offers prostate cancer patients in India a new integrative option—not as a replacement for conventional treatment, but as a supportive therapy to strengthen immunity, reduce side effects, and improve quality of life.

With the arrival of ABNOBA India, patients can now access this European integrative therapy within a structured and medically supervised framework.



Comments

Post a Comment

Popular posts from this blog

Exploring the Healing Potential of Mistletoe Therapy in Cancer Care

Image
 Mistletoe therapy, long integrated into European oncology practices, is gaining global recognition for its ability to enhance the overall well-being of cancer patients. Manufactured by ABNOBA GmbH , a leading German research-based pharmaceutical company, mistletoe extracts are now accessible in India through ABNOBA India , bringing a powerful complementary approach to supportive cancer care. Unlike conventional treatments that directly target tumors, mistletoe therapy works by stimulating the body’s own defenses . Its active ingredients, including mistletoe lectins , help activate immune cells and regulate the immune response—crucial during cancer treatment, when immunity is often compromised. One of mistletoe therapy’s most appreciated benefits is its impact on quality of life . Clinical studies have shown that patients receiving mistletoe extracts often report reduced treatment-related fatigue , nausea , and emotional distress , leading to better energy levels and a more stabl...
Read more

Unlocking the Healing Potential of Mistletoe Extracts in Modern Medicine

Image
Mistletoe ( Viscum album ) is more than just a symbol of tradition—it holds immense therapeutic promise in the field of integrative oncology. For decades, mistletoe extracts have been utilized in Europe, particularly in German-speaking countries, as a supportive treatment for cancer patients. Their role in enhancing immune function, improving tolerance to chemotherapy, and increasing overall well-being is well documented through scientific and clinical research. ABNOBA GmbH , a reputable German pharmaceutical company based in Pforzheim, is a pioneer in the development and production of standardized mistletoe extracts. With a commitment to scientific rigor and patient safety, ABNOBA ensures that its products maintain high levels of purity, consistency, and efficacy. Through ABNOBA India, these advanced therapies are now accessible to a wider patient base in South Asia, bridging the gap between traditional European therapies and modern Indian medical practices. The therapeutic compoun...
Read more

Scientific Evidence Supporting Mistletoe Therapy in Oncology

Image
Mistletoe therapy, derived from the European mistletoe plant ( Viscum album ), has gained attention as a complementary treatment in oncology, particularly in German-speaking countries. ABNOBA GmbH, a research-driven pharmaceutical company based in Pforzheim, Germany, has been at the forefront of developing standardized mistletoe extracts used in integrative cancer care. Scientific investigations over the past few decades have supported the potential benefits of mistletoe therapy in cancer treatment . Preclinical studies indicate that mistletoe extracts possess immunomodulatory, apoptotic (cell death-inducing), and cytotoxic effects against various tumor cell lines. These properties are largely attributed to mistletoe lectins and viscotoxins, key bioactive compounds in the extract. Clinical research, including randomized controlled trials, has shown that mistletoe therapy can improve quality of life, reduce chemotherapy side effects such as fatigue and nausea, and possibly extend surv...
Read more